Literature DB >> 8892491

Health status and hypertension: a population-based study.

W F Lawrence1, D G Fryback, P A Martin, R Klein, B E Klein.   

Abstract

We describe the relation between self-reported hypertension and measures of health-related quality of life (HRQOL) in a community-dwelling population. In a cross-sectional study, 1430 randomly selected adults, aged 45 to 89 years, were interviewed to obtain a medical history and health status measures, including the SF-36 questionnaire, the Quality of Well Being (QWB) index, and time trade-off (TTO) assessments. A total of 519 participants reported being affected by hypertension (HTN group). The HTN group, compared to the No HTN group, had significantly lower age-adjusted health status scores measured by the General Health scale of the SF-36 and by TTO, with differences between groups for each measure comprising approximately 5% of the total scale. HTNs also had a significant decline in general health status measures associated with increasing numbers of antihypertensive medications but not with specific classes of medications. We conclude that hypertension and hypertension drug therapy are associated with clinically meaningful decreases in reported health status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892491     DOI: 10.1016/s0895-4356(96)00220-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  28 in total

1.  Is adherence to drug treatment correlated with health-related quality of life?

Authors:  Isabelle Côté; Karen Farris; David Feeny
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

2.  Self rated health and mortality: a long term prospective study in eastern Finland.

Authors:  S Heistaro; P Jousilahti; E Lahelma; E Vartiainen; P Puska
Journal:  J Epidemiol Community Health       Date:  2001-04       Impact factor: 3.710

3.  The diagnosis of asymptomatic disease is associated with fewer healthy days: A cross sectional analysis from the national health and nutrition examination survey.

Authors:  Janel Hanmer; Lan Yu; Jie Li; Dio Kavalieratos; Laurel Peterson; Rachel Hess
Journal:  Br J Health Psychol       Date:  2018-09-28

4.  Psychometric properties of the VSQLQ in black patients with mild hypertension. Vital Signs Quality of Life Questionnaire.

Authors:  N K Leidy; J K Schmier; A E Bonomi; M Legro; T Zyczynski; B W Kong
Journal:  J Natl Med Assoc       Date:  2000-12       Impact factor: 1.798

5.  Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

Authors:  Phillip D Levy; Robina Josiah Willock; Michael Burla; Aaron Brody; James Mahn; Alexander Marinica; Samar A Nasser; John M Flack
Journal:  J Am Soc Hypertens       Date:  2016-10-28

6.  Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.

Authors:  Michael J Twiner; Alexander L Marinica; Kenneth Kuper; Allen Goodman; James J Mahn; Michael J Burla; Aaron M Brody; Justin A Carroll; Robina Josiah Willock; John M Flack; Samar A Nasser; Phillip D Levy
Journal:  Acad Emerg Med       Date:  2017-01-30       Impact factor: 3.451

Review 7.  Cost effectiveness of coronary heart disease prevention strategies in adults.

Authors:  A D Brown; A M Garber
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

8.  Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study.

Authors:  E-M Chia; P Mitchell; E Rochtchina; S Foran; J J Wang
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 9.  Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers).

Authors:  Antonio Coca
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

10.  Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life.

Authors:  Tamara Poljicanin; Dea Ajduković; Mario Sekerija; Mirjana Pibernik-Okanović; Zeljko Metelko; Gorka Vuletić Mavrinac
Journal:  BMC Public Health       Date:  2010-01-13       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.